{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:35:16Z","timestamp":1775849716854,"version":"3.50.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Risk stratification for CMV infection in lung transplantation (LT) currently relies on determining donor and recipient CMV IgG before transplantation. However, it has been observed that some patients who test positive for CMV-specific humoral response before kidney transplantation (KT) exhibit a weak or absent CMV-specific cellular response. The significance of this observation in LT is still unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This prospective, multicenter, observational study evaluated the agreement between CMV IgG serology and specific cell-mediated response (specific T cell Enzyme-Linked ImmunoSpot Assay, ELISPOT, against CMV pp65 and IE-1 antigens) in 121 patients on the waiting list for LT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and four (86%) patients were seropositive for CMV. Discordant humoral and cellular immunologic responses were observed, 29% of seropositive patients had a weak ELISPOT response to IE-1 and 39% to pp65. In 22% of seropositive patients, there was a weak or no response to both antigens. All seronegative patients did not respond to either antigen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Therefore, over 20% of CMV seropositive LT candidates showed weak CMV-specific cellular immune responses despite detectable serological memory against CMV. This may be important in assessing the risk of developing a CMV infection after transplantation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1445553","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:12:41Z","timestamp":1737529961000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation"],"prefix":"10.3389","volume":"15","author":[{"given":"Meritxell","family":"Boada-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Berastegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Erro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piedad","family":"Ussetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Donadeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Bestard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Anguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Ponz Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Revilla-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"G\u00f3mez-Oll\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-012-0292-2","article-title":"Cytomegalovirus in solid organ transplantation: Epidemiology, prevention, and treatment","volume":"14","author":"Beam","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2016.04.001","article-title":"Management of cytomegalovirus infection in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations","volume":"30","author":"Torre-Cisneros","year":"2016","journal-title":"Transplant Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00505.x","article-title":"Cytomegalovirus and lung transplantation","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplantation"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000061607.07985.BD","article-title":"Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients","volume":"75","author":"Danziger-Isakov","year":"2003","journal-title":"Transplantation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2042-4280-2-6","article-title":"Cytomegalovirus-induced immunopathology and its clinical consequences","volume":"2","author":"Varani","year":"2011","journal-title":"Herpesviridae"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/frtra.2024.1388393","article-title":"Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword","volume":"3","author":"Bharti","year":"2024","journal-title":"Front Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clim.2013.03.012","article-title":"CMV driven CD8+ T-cell activation is associated with acute rejection in lung transplantation","volume":"148","author":"Roux","year":"2013","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20907.x","article-title":"The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients","volume":"2","author":"Sagedal","year":"2002","journal-title":"Am J Transplantation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.05.028","article-title":"Combined cytomegalovirus prophylaxis in lung transplantation: effects on acute rejection, lymphocytic bronchitis\/bronchiolitis, and herpesvirus infections","volume":"40","author":"Solidoro","year":"2008","journal-title":"Transplant Proc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.12.8","article-title":"The immune response to human CMV","volume":"7","author":"la Rosa","year":"2012","journal-title":"Future Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03663.x","article-title":"Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome","volume":"11","author":"Paraskeva","year":"2011","journal-title":"Am J Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-022-00551-0","article-title":"Cytomegalovirus infection is associated with development of chronic lung allograft dysfunction","volume":"200","author":"Bennett","year":"2022","journal-title":"Lung"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2018.10.034","article-title":"Long-term impact of cytomegalovirus serologic status on lung transplantation in the United States","volume":"107","author":"Kurihara","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: A review","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect Chemother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/tid.2017.19.issue-3","article-title":"Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study","volume":"19","author":"Monforte","year":"2017","journal-title":"Transplant Infect Disease"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02574.x","article-title":"A multicenter study of valganciclovir prophylaxis up to day 120 in CMV-Seropositive lung transplant recipients","volume":"9","author":"Monforte","year":"2009","journal-title":"Am J Transplantation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/tid.2013.15.issue-2","article-title":"Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis","volume":"15","author":"Hammond","year":"2013","journal-title":"Transplant Infect Disease"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.02.017","article-title":"Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial","volume":"30","author":"Finlen Copeland","year":"2011","journal-title":"J Heart Lung Transplantation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181ea3955","article-title":"An international survey of cytomegalovirus management practices in lung transplantation","volume":"90","author":"Zuk","year":"2010","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx062","article-title":"Impact of donor and recipient human cytomegalovirus status on kidney transplantation","volume":"29","author":"Zieli\u0144ski","year":"2017","journal-title":"Int Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/cid\/ciu589","article-title":"Preformed frequencies of cytomegalovirus (CMV)\u2013specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients","volume":"59","author":"L\u00facia","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001825","article-title":"CMV-specific T cell monitoring offers superior risk stratification of CMV-seronegative kidney transplant recipients of a CMV-seropositive donor","volume":"101","author":"Schachtner","year":"2017","journal-title":"Transplantation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.3390\/diagnostics11091688","article-title":"Comparison of humoral and cellular CMV immunity in patients awaiting kidney transplantation","volume":"11","author":"Lindemann","year":"2021","journal-title":"Diagnostics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002421","article-title":"CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+\/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy","volume":"102","author":"Jarque","year":"2018","journal-title":"Transplantation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa727","article-title":"CMV-specific cell-mediated immunity predicts a high level of CMV replication after prophylaxis withdrawal in lung transplant recipients","volume":"224","author":"Donadeu","year":"2021","journal-title":"J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12256","article-title":"Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1209","article-title":"Cellular immunity to predict the risk of cytomegalovirus infection in kidney transplantation: A prospective, interventional, multicenter clinical trial","volume":"71","author":"Jarque","year":"2020","journal-title":"Clin Infect Diseases"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2004.02.014","article-title":"CD8+ T-cell immunity to cytomegalovirus","volume":"65","author":"Moss","year":"2004","journal-title":"Hum Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.9.5400-5413.2005","article-title":"Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting","volume":"79","author":"Pahl-Seibert","year":"2005","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12049","article-title":"Pretransplant interferon-\u03b3 secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation","volume":"13","author":"Cantis\u00e1n","year":"2013","journal-title":"Am J Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1753466620981851","DOI":"10.1177\/1753466620981851","article-title":"Cellular and humoral cytomegalovirus immunity changes in one-year combined prophylaxis after lung transplantation: suggestions from and for clinical practice","volume":"14","author":"Solidoro","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa750","article-title":"Pretransplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: A prospective cohort study","volume":"224","author":"Altaf","year":"2021","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1\u2013specific CD8 T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplantation"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: A multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Diseases"},{"key":"B38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/TP.0b013e31823c1cd4","article-title":"Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia","volume":"93","author":"Lisboa","year":"2012","journal-title":"Transplantation"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplantation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04076.x","article-title":"Prospective analysis of human cytomegalovirus DNAemia and specific CD8+ T cell responses in lung transplant recipients","volume":"12","author":"Weseslindtner","year":"2012","journal-title":"Am J Transplantation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002454","article-title":"A randomized study of quantiferon CMV-directed versus fixed-duration valganciclovir prophylaxis to reduce late CMV after lung transplantation","volume":"103","author":"Westall","year":"2019","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2021.10.002","article-title":"Assessment of quantiferon\u00ae-CMV and immuknow\u00ae Assays in CMV-seropositive lung transplant recipients to stratify risk of CMV infection","volume":"58","author":"Monforte","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030648","article-title":"Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial","volume":"9","author":"Paez-Vega","year":"2019","journal-title":"BMJ Open"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189488","article-title":"Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients","volume":"12","author":"Lee","year":"2017","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015228","article-title":"Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation: A PRISMA-compliant article","volume":"98","author":"Ruan","year":"2019","journal-title":"Medicine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1479-5876-6-29","article-title":"Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients","volume":"6","author":"Egli","year":"2008","journal-title":"J Transl Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02191.x","article-title":"Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation","volume":"8","author":"Mattes","year":"2008","journal-title":"Am J Transplantation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02279.x","article-title":"PD-1 expression and IL-2 loss of cytomegalovirus- specific t cells correlates with viremia and reversible functional anergy","volume":"8","author":"Sester","year":"2008","journal-title":"Am J Transplantation"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200301150-00030","article-title":"Association of glycoprotein B and immediate early-1 genotypes with human leukocyte antigen alleles in renal transplant recipients with cytomegalovirus infection","volume":"75","author":"Reti\u00e8re","year":"2003","journal-title":"Transplantation"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.08.058","article-title":"Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination","volume":"24","author":"Bauer","year":"2006","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1445553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:12:45Z","timestamp":1737529965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1445553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2024.1445553"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1445553","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"article-number":"1445553"}}